HCIT & Life Sciences

The intersection of trends in HCIT and Life Sciences technology is a core thesis that we continue to applaud. These intersecting technologies not only allow providers to understand patients better, but can also deliver customized experiences in addition to elevating health care engagement.

HCIT & Life Sciences

 Transactions

Throughout Bernoulli's acquisition process—one that is to be critical in supporting and enabling the Company's next phase of growth—we knew we needed a financial advisor that would act as a true business partner. We wanted a team that would help guide us through meetings and narrow down the investor field, while still allowing us to make the decisions that were best for Bernoulli. We chose Hugh Hoffman and AGC Partners because of their expertise in the HCIT sector of the technology industry and like-minded dedication to maintaining Bernoulli's core business values. With the support of AGC Partners, Bernoulli was able to secure a terrific outcome for our investors, shareholders, customers and employees.

Janet Dillione, CEO, Bernoulli

AGC Partners acted as sole financial advisor to Bernoulli in April, 2019

"Our company presented an interesting challenge for even the most skilled Strategic Advisor. Knowing our situation was somewhat unique and complex, we carefully selected our partner for this process. The AGC team had solid subject matter expertise and their approach to our engagement was thoughtful and ultimately produced a very positive outcome for our shareholders, customers, employees and the acquiring business. Fred and his team played a key role in the timing of the process, the positioning of the business overall and in every stage leading to Closing. I would highly recommend AGC and Fred and hope to have the opportunity to work with them again in the future."

Bob Renner, CEO, Liaison

Get in touch and experience the AGC difference